Cargando…

N(6)-Methyladenosine (m(6)A): A Promising New Molecular Target in Acute Myeloid Leukemia

Recent studies have uncovered an important role for RNA modifications in gene expression regulation, which led to the birth of the epitranscriptomics field. It is now acknowledged that RNA modifiers play a crucial role in the control of differentiation of stem and progenitor cells and that changes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ianniello, Zaira, Paiardini, Alessandro, Fatica, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465620/ https://www.ncbi.nlm.nih.gov/pubmed/31024852 http://dx.doi.org/10.3389/fonc.2019.00251

Ejemplares similares

N6-Methyladenosine Role in Acute Myeloid Leukaemia
por: Ianniello, Zaira, et al.
Publicado: (2018)

Interplay Between N(6)-Methyladenosine (m(6)A) and Non-coding RNAs in Cell Development and Cancer
por: Fazi, Francesco, et al.
Publicado: (2019)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia
por: Zheng, Xue, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

RNA N6-methyladenosine: a promising molecular target in metabolic diseases
por: Li, Yan, et al.
Publicado: (2020)

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
por: Li, Gaofeng, et al.
Publicado: (2022)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

Molecular Characterization and Clinical Relevance of N(6)-Methyladenosine Regulators in Metastatic Prostate Cancer
por: Liu, Qiwei, et al.
Publicado: (2022)

Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer
por: Tian, Shuoran, et al.
Publicado: (2021)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells
por: Vu, Ly P., et al.
Publicado: (2017)

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development
por: Liu, Shougeng, et al.
Publicado: (2022)

N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer
por: Yu, Sihui, et al.
Publicado: (2019)

RNA N (6)-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
por: Dang, Qin, et al.
Publicado: (2021)

Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers
por: Dai, Xin-Yuan, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

N(6)-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1
por: Wang, Duo, et al.
Publicado: (2021)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players
por: Fatica, Alessandro
Publicado: (2012)

Transcriptome-Wide Analysis of RNA N(6)-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells
por: Fang, Shu, et al.
Publicado: (2022)

Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
por: Magliulo, Daniela, et al.
Publicado: (2018)

The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
por: Zhang, Yi, et al.
Publicado: (2023)

Regulation of Ribosome Function by RNA Modifications in Hematopoietic Development and Leukemia: It Is Not Only a Matter of m(6)A
por: Fazi, Francesco, et al.
Publicado: (2021)

Transcriptome-Wide Map of N(6)-Methyladenosine Methylome Profiling in Human Bladder Cancer
por: Li, Aolin, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

A Ten-N(6)-Methyladenosine (m(6)A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma
por: Huang, Wei, et al.
Publicado: (2021)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1
por: Huang, Chunxian, et al.
Publicado: (2021)

RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA
por: Fan, Jin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sa98vajrvihu9a3movj8kpq0s7